DLB Valuation

Dolby Laboratories Inc

Add to Watchlist

Advanced Chart

76.360

+0.03(0.039%)1D

Overview
Forecast
Valuation
Earnings

DLB Relative Valuation

DLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DLB is overvalued; if below, it's undervalued.

Historical Valuation

Dolby Laboratories Inc (DLB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 19.41 is considered Undervalued compared with the five-year average of 22.71. The fair price of Dolby Laboratories Inc (DLB) is between 90.82 to 111.28 according to relative valuation methord. Compared to the current price of 76.33 USD , Dolby Laboratories Inc is Undervalued By 15.96%.

Relative Value

Fair Zone

90.82-111.28

Current Price：76.33

15.96%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.85

P/B

Median3y

3.16

Median5y

3.26

5.29

FCF Yield

Median3y

4.26

Median5y

4.14

Competitors Valuation Multiple

The average P/S ratio for DLB's competitors is 6.03, providing a benchmark for relative valuation. Dolby Laboratories Inc Corp (DLB) exhibits a P/S ratio of 5.39, which is -10.68% above the industry average. Given its robust revenue growth of 1.38%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

DLB.N

Dolby Laboratories Inc

5.39

Average P/S: 6.03

1.38%